Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.

Samira KhaniSeyed Amir HejaziMehdi YaghoubiEhsan Sharifipour

Published in: The journal of headache and pain (2021)

The obtained results of this study revealed that magnesium could enhance the antimigraine properties of sodium valproate in combination therapy and reduce the required valproate dose for migraine prophylaxis.

Keyphrases

combination therapy
clinical trial
phase iii
double blind
study protocol
phase ii
single cell
stem cells
open label
locally advanced
mesenchymal stem cells
cell therapy
rectal cancer
replacement therapy